1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)$

ABCL - 853

Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)

Mohamad Cherry

Poster Presenter: Mohamad Cherry

Video

Thumbnail for waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

ABCL - 313

waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Melissa Drysdale

Poster Presenter: Melissa Drysdale

ABCL - 1743

Wealth Predicts Survival, Not Incidence: Sociodemographic Disparities in the Global Burden of Burkitt Lymphoma, 1990-2023

Amit Banerjee

Poster Presenter: Amit Banerjee

Thumbnail for Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

AML - 292

Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

MM - 494

When Can MRD Change Management? A Cross-Disease Review of MRD-Guided Therapy in Hematologic Malignancies

Mansha Gupta

Poster Presenter: Mansha Gupta

Thumbnail for When Fat Fuels Plasma Cell Malignancy: Three Decades of Multiple Myeloma Mortality Attributable to High BMI Across 204 Countries, 1990–2023

MM - 1752

When Fat Fuels Plasma Cell Malignancy: Three Decades of Multiple Myeloma Mortality Attributable to High BMI Across 204 Countries, 1990–2023

Kashish Magnani

Poster Presenter: Kashish Magnani

Thumbnail for When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy under Teclistamab in Lambda Light Chain Myeloma

MM - 451

When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy under Teclistamab in Lambda Light Chain Myeloma

Nour Haidar

Poster Presenter: Nour Haidar

MM - 1654

When Is Stopping Safe? Fixed-Duration Therapy and Treatment-Free Remission in Hematologic Malignancies: A Scoping Review

Mansha Gupta

Poster Presenter: Mansha Gupta

ABCL - 200

When Presentation Misleads: Diagnostic Challenges in Extranodal Diffuse Large B-Cell Lymphoma

Mihaela-Sabrina Herdea

Poster Presenter: Mihaela-Sabrina Herdea